Medical Cannabis for Insomnia in a Patient With Advanced Breast Cancer

      A 49-year-old female with history of estrogen receptor (ER)/progesterone receptor (PR) positive human epidermal growth factor receptor-2 (HER-2) negative breast cancer gene-1 (BRCA-1) negative, multifocal invasive ductal carcinoma, presented with a 2 cm left breast mass and two of 26 positive lymph nodes. She is status post left mastectomy with axillary lymph node dissection and immediate reconstruction with tissue expander 12 years ago. She also had risk reduction right mastectomy with a tissue expander, and no cancer was found in the right breast. She then underwent adjuvant chemotherapy with doxorubicin and cyclophosphamide, followed by paclitaxel. She received chest wall and regional nodal radiation, completed 11 years ago. Patient was started on tamoxifen, however rotated to toremifene due to tamoxifen intolerance.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Pain and Symptom Management
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Braithwaite I
        • Bhagavan C
        • Doppen M
        • et al.
        Medicinal applications of cannabis/cannabinoids.
        Curr Opin Psychol. 2021; 38: 1-10
        • Sutton EL
        Ann Intern Med. 2021; 174: Itc33-itc48
        • Zhang J
        • Zhang Z
        • Huang S
        • et al.
        Acupuncture for cancer-related insomnia: A systematic review and meta-analysis.
        Phytomedicine. 2022; 102154160
        • Kwak A
        • Jacobs J
        • Haggett D
        • et al.
        Evaluation and management of insomnia in women with breast cancer.
        Breast Cancer Res Treat. 2020; 181: 269-277
        • Bean HR
        • Diggens J
        • Ftanou M
        • et al.
        Insomnia and fatigue symptom trajectories in breast cancer: a longitudinal cohort study.
        Behav Sleep Med. 2021; 19: 814-827
        • Palesh OG
        • Roscoe JA
        • Mustian KM
        • et al.
        Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program.
        J Clin Oncol. 2010; 28: 292-298
        • Lis CG
        • Gupta D
        • Grutsch JF
        The relationship between insomnia and patient satisfaction with quality of life in cancer.
        Support Care Cancer. 2008; 16: 261-266
        • Collins KP
        • Geller DA
        • Antoni M
        • et al.
        Sleep duration is associated with survival in advanced cancer patients.
        Sleep Med. 2017; 32: 208-212
        • Ruel S
        • Ivers H
        • Savard M
        • et al.
        Insomnia, immunity, and infections in cancer patients: Results from a longitudinal study.
        Health Psychol. 2020; 39: 358-369
        • Rentscher KE
        • Carroll JE
        • Juckett MB
        • et al.
        Sleep disruption, fatigue, and depression as predictors of 6-year clinical outcomes following allogeneic hematopoietic cell transplantation.
        J Natl Cancer Inst. 2021; 113: 1405-1414
        • Palesh O
        • Aldrige-Gerry A
        • Zeitzer JM
        • et al.
        Actigraphy-measured sleep disruption as a predictor of survival among women with advanced breast cancer.
        Sleep. 2014; 37: 837-842
        • Steel JL
        • Terhorst L
        • Collins KP
        • et al.
        Prospective analyses of cytokine mediation of sleep and survival in the context of advanced cancer,.
        Psychosom Med. 2018; 80: 483-491
        • Borgelt LM
        • Franson KL
        • Nussbaum AM
        • Wang GS
        The pharmacologic and clinical effects of medical cannabis.
        Pharmacotherapy. 2013; 33: 195-209
        • Freeman TP
        • Craft S
        • Wilson J
        • et al.
        Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis.
        Addiction. 2021; 116: 1000-1010
        • Corroon J
        Cannabinol and sleep: separating fact from fiction.
        Cannabis Cannabinoid Res. 2021; 6: 366-371
        • Liktor-Busa E
        • Leresztes A
        • LaVigne J
        • Streicher JM
        • Largent-Milnes TM
        Analgesic potential of terpenes derived from cannabis sativa.
        Pharmacol Rev. 2021; 73: 98-126
        • Tomko AM
        • Whynot EG
        • Ellis LD
        • Dupre DJ
        Anti-cancer potential of cannabinoids, terpenes, and flavonoids present in cannabis.
        Cancers (Basel). 2020; 121985
        • Freemon FR
        The effect of chronically administered delta-9-tetrahydrocannabinol upon the polygraphically monitored sleep of normal volunteers.
        Drug Alcohol Depend. 1982; 10: 345-353
        • Babson KA
        • Sottile J
        • Morabito D
        Cannabis, cannabinoids, and sleep: a review of the literature.
        Curr Psychiatry Rep. 2017; 19: 23
        • Bolla KI
        • Lesage R
        • Gamaldo CE
        • et al.
        Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence.
        Sleep Med. 2010; 11: 882-889
        • Nicholson AN
        • Turner C
        • Stone BM
        • Robson PJ
        Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults.
        J Clin Psychopharmacol. 2004; 24: 305-313
        • Carlini EA
        • Cunha JM
        Hypnotic and antiepileptic effects of cannabidiol.
        J Clin Pharmacol. 1981; 21: 417s-427s
        • Lucas CJ
        • Galettis P
        • Schneider J
        The pharmacokinetics and the pharmacodynamics of cannabinoids.
        Br J Clin Pharmacol. 2018; 84: 2477-2482
        • Zendulka O
        • Dovrtělová G
        • Nosková K
        • et al.
        Cannabinoids and cytochrome P450 interactions.
        Curr Drug Metab. 2016; 17: 206-226
        • Lopera V
        • Rodríguez A
        • Amariles P
        Clinical relevance of drug interactions with cannabis: a systematic review.
        J Clin Med. 2022; 111154
        • Bar-Sela G
        • Cohen I
        • Campisi-Pinto S
        • et al.
        Cannabis consumption used by cancer patients during immunotherapy correlates with poor clinical outcome.
        Cancers (Basel). 2020; 122447
        • Whiting PF
        • Wolff RF
        • Deshpande S
        • et al.
        Cannabinoids for medical use: a systematic review and meta-analysis.
        Jama. 2015; 313: 2456-2473
        • Walsh JH
        • Maddison KJ
        • Rankin T
        • et al.
        Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo.
        Sleep. 2021; 44zsab149
        • Brodie MJ
        • Czapinski P
        • Pazdera L
        • et al.
        A Phase 2 randomized controlled trial of the efficacy and safety of cannabidivarin as add-on therapy in participants with inadequately controlled focal seizures.
        Cannabis Cannabinoid Res. 2021; 6: 528-536
        • Lichtman AH
        • Lux EA
        • McQuade R
        • et al.
        Results of a double-blind, randomized, placebo-controlled study of nabiximols oromucosal spray as an adjunctive therapy in advanced cancer patients with chronic uncontrolled pain.
        J Pain Symptom Manage. 2018; 55: 179-188.e1
        • Turcott JG
        • Del Rocio Guillen Nunez M
        • Flores-Estrada D
        • et al.
        The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial, Support Care Cancer. 2018; 26: 3029-3038
        • AminiLari M
        • Wang L
        • Neumark S
        • et al.
        Medical cannabis and cannabinoids for impaired sleep: a systematic review and meta-analysis of randomized clinical trials.
        Sleep. 2022; 45: 1-11
        • Côté M
        • Trudel M
        • Wang C
        • Fortin A
        Improving quality of life with nabilone during radiotherapy treatments for head and neck cancers: a randomized double-blind placebo-controlled trial.
        Ann Otol Rhinol Laryngol. 2016; 125: 317-324
        • Johnson JR
        • Burnell-Nugent M
        • Lossignol D
        • Genae-Motan ED
        • Potts R
        • Fallon MT
        Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain.
        J Pain Symptom Manage. 2010; 39: 167-179
        • Almeida CF
        • Teixeira N
        • Correia-da-Silva G
        • Amaral C
        Cannabinoids in breast cancer: differential susceptibility according to subtype.
        Molecules. 2021; 27156
        • Amaral C
        • Trouille FM
        • Ferreira Almeida C
        • Correia-da-Silva G
        • Teixeira N
        Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER(+) breast cancer cells: Impact on aromatase and steroid receptors.
        J Steroid Biochem Mol Biol. 2021; 210: 105876
        • Dobovišek L
        • Krstanovic F
        • Borstnar S
        • Debeljak N
        Cannabinoids and hormone receptor-positive breast cancer treatment.
        Cancers (Basel). 2020; 12525
        • Taha T
        • Meiri D
        • Talhamy S
        • Wollner M
        • Peer A
        • Bar-Sela G
        Cannabis impacts tumor response rate to nivolumab in patients with advanced malignancies.
        Oncologist. 2019; 24: 549-554
        • Biedny A
        • Szpunar S
        • Abdalla A
        • Kafri Z
        • Hadid TH
        The effect of concomitant cannabinoids during immune checkpoint inhibitor treatment of advanced stage malignancy.
        J Clin Oncol. 2020; 38(15_suppl)e15064
        • Bialas P
        • Bottge-Wolpers C
        • Fitzcharles M
        • et al.
        Cannabis use disorder in chronic pain patients: over- and underestimation in a cross-sectional observational study in three German pain management centres.
        PAIN. 2022;
        • Suraev AS
        • Marshall NS
        • Vandrey R
        • et al.
        Cannabinoid therapies in the management of sleep disorders: a systematic review of preclinical and clinical studies.
        Sleep Med Rev. 2020; 53: 101339